Presentation TCT 2017 FDA Perspectives: Devices to Control Hypertension - Patient Populations, Endpoints and Other Considerations Presenter: Hiren Mistry, Michael A. Weber October 31, 2017
Presentation TCT 2017 Renal Denervation Trial Design Considerations: Challenges and Lessons Learned Presenter: Hiren Mistry, Michael A. Weber, Michael Böhm October 31, 2017
Presentation TCT 2017 What Needs to Be Shown Before Renal Denervation Can Be Used in Clinical Practice? Presenter: Michael Böhm, Thomas F. Luscher, Michael A. Weber October 30, 2017
Presentation TCT 2017 Vessix RE-INFORCE Trial Update Presenter: Michael Böhm, Thomas F. Luscher, Michael A. Weber October 30, 2017
Presentation TCT 2017 Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios Presenter: Sidney C. Smith, Michael A. Weber October 30, 2017
Presentation TCT 2017 What is the Optimal Therapy for Hypertension? Presenter: Sidney C. Smith, Michael A. Weber October 30, 2017
Presentation TCT 2017 Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials Presenter: Sidney C. Smith, Michael A. Weber, C. Venkata S. Ram October 30, 2017
Presentation TCT 2017 New U.S. Hypertension Guidelines and Treatment Targets Presenter: Sidney C. Smith, Michael A. Weber, Sandra J Taler October 30, 2017
Presentation TCT 2017 Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice Presenter: Sidney C. Smith, Michael A. Weber, Vasilios Papademetriou October 30, 2017